Skip to main content

APO LET 2.5 Pill: yellow, round, 7mm

The pill with imprint APO LET 2.5 (Yellow, Round, 7mm) has been identified as Letrozole 2.5 mg and is used for Breast Cancer, Adjuvant, Breast Cancer, Metastatic, and Breast Cancer. It belongs to the drug classes aromatase inhibitors, hormones/antineoplastics and is not a controlled substance.

Images for APO LET 2.5

Letrozole 2.5 mg APO LET 2.5
Letrozole 2.5 mg APO LET 2.5
Letrozole 2.5 mg APO LET 2.5
Letrozole 2.5 mg APO LET 2.5

Letrozole

Imprint
APO LET 2.5
Strength
2.5 mg
Color
Yellow
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Inactive Ingredients
hydroxypropyl cellulose, hypromelloses, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 8000, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
60505-3255 (Discontinued) Apotex Corp.
68084-0803 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.